• About Pharmetheus
    • History
    • Mission & Values
    • Leadership
    • Scientific advisors
    • Our team
    • Social impact (CSR)
    • Contexts of use
      • Trial design and analysis
      • Program strategies and efficiences
      • Special/specific populations
      • Special considerations
      • Regulatory interactions
    • Pharmetheus Platforms
      • Model-Informed Drug Development
      • PBPK & PBBM
      • Pharmacometrics
      • QSP
    • Solutions
      • Milestone Analysis
      • Embedded Scientists
      • Expert Advice
      • Scientific Publication
    • Specific services
      • Model-Informed Bioequivalence 
& Biosimilarity
      • Accelerated submission
      • Concentration-QTc (C-QTc) modeling
      • Data-driven strategies for pediatric success
      • Training workshops
      • Publications
      • Case studies
      • Articles
    • Working with us
    • Open positions
    • Employee stories
    Qing Xi Ooi supports clients with hands-on analysis and strategic advice

    Qing Xi Ooi supports clients with hands-on analysis and strategic advice

    Viviana Moroso brings scientific depth to quality control

    Viviana Moroso brings scientific depth to quality control

    Siv Jönsson develops Pharmetheus’s learning agenda

    Siv Jönsson develops Pharmetheus’s learning agenda

  • Events
  • News
  • Contact us
  1. Home
  2. News
  3. Pharmetheus passes 100 employees and moves to new office in central Uppsala

Share on:

  • Facebook
  • LinkedIn

Pharmetheus passes 100 employees and moves to new office in central Uppsala

Pharmetheus AB has reached a capacity milestone with more than one hundred persons on the team, and relocates to new headquarters next to Uppsala Central Station, a strategic move to accommodate the growing need of its services, driving the expansion of the team.

04.09.2024

Pharmetheus passes 100 employees and moves to new office in central Uppsala
Pharmetheus passes 100 employees and moves to new office in central Uppsala

Pharmetheus AB is happy to announce two significant events, highlighting its capacity and future ambitions. The company has organically grown its team past 100 employees, and is relocating its headquarters to a sustainability flagship in central Uppsala, allowing for an easy commute for the employees and its global clients. CEO, Peter Milligan, reflects on the development:

– When I joined Pharmetheus in 2019, my mission was clear: to manage our growth in a way that would expand and amplify the range of services we provide.

 

Portrait-of-Peter-Milligan-Pharmetheus-2048x1280.jpg (1)
Dr. Peter Milligan, CEO of Pharmetheus (2019–2026).

More than a hundred

A critical mass of skilled modelers, data programmers, QC/Medical Writers and system developers, positions the company to meet complex needs of multiple clients. With more than 100 on the team, there is enough capacity to deliver across various project sizes and scopes, without compromising quality, the very core of the business.

Peter Milligan explains:

– It’s not about having over 100 team members, even if size does matter to an extent. It is about the diversity of expertise we can provide to clients. We can offer a broad range of expertises in therapeutic areas such as oncology, respiratory, and inflammatory diseases, along with a growing research and development team, we are positioned to offer robust fit for purpose support to our clients.

Pharmetheus serves global pharmaceutical clients with modeling and simulation services throughout the product lifecycle. The services reduce uncertainty in research and regulatory questions, and increase confidence in the development of new medicines. 

 

With a growing research and development team, we are positioned to offer robust fit for purpose support to our clients

The aspiration is to be more than a service provider – to be the partner of choice. 

– Working in partnership means we support our clients’ growth, and in return they challenge us to better anticipate their needs. Through collaboration we are more likely to overcome these challenges together and to seize the opportunities presented by new discoveries, methods, modalities and applications, says Peter Milligan.

 

HQ relocation

With this transition to a spacious, modern office in a prime central location, we aim to accommodate clients and employees.

Pharmetheus_Milestone_NewUppsalaHQ_LUMI-1-2048x1280.jpg
A sustainability and recycling project – the LUMI business complex.
The new headquarters is within walking distance of Uppsala Central Station allowing the company the opportunity to host and organize larger networking events, of which the first on the new premises is the Stockholm-Uppsala Pharmacometrics (SUP) fall meeting on October 10, themed “Semi-mechanistic models developed based on PK and/or PD data”.

– We are thrilled the organizing committee has chosen our office for their fall meeting. Relocating has been on our agenda for some time, as we outgrew our current premises during the COVID-19 pandemic. With this transition to a spacious, modern office in a prime central location, we aim to accommodate clients and employees.

About the Lumi office building

The building itself has received attention in construction and architect communities for being a construction project focused on sustainability, with 80 percent recycled building material, refurbished furniture and interiors. It is a rebuild of an old building, where the ambition has been to re-use as much of the material as possible, and also to keep the use of new material to an absolute minimum. Tenants have committed to using refurbished furniture and are dedicated to the mission of a low environmental footprint.

Read more about the Lumi project on these links:

  • White Arkitekter

  •  

    Vasakronan (In Swedish)

Pharmetheus_Milestone_NewUppsalaHQ_LUMI-2048x1280.jpg

 

Press contact

Martina Lundgren
Head of Marketing & Communications

Email: marketing@pharmetheus.com

Related content

Stringency and clarity for confidence in Physiologically Based (PB) modeling

21/09/26

Stringency and clarity for confidence in Physiologically Based (PB) modeling

Author: Erik Sjögren, Scientific Lead for PBPK and PBBM

Peter Milligan, retiring CEO of Pharmetheus, wins 2026 ISoP Leadership Award

16/09/26

Peter Milligan, retiring CEO of Pharmetheus, wins 2026 ISoP Leadership Award

Following over seven years at the helm, outgoing CEO Peter Milligan leaves Pharmetheus on a high...

Global talent connect at Uppsala Pharmacometrics Summer School 2026

18/08/26

Global talent connect at Uppsala Pharmacometrics Summer School 2026

Connecting emerging scientists from around the globe, the Uppsala Pharmacometrics Summer School...


Contact

Pharmetheus AB
Kungsängstull 4 

753 19 Uppsala, Sweden

Visiting address: 

Dragarbrunnsgatan 77, 5th floor

  • LinkedIn
  • YouTube
  • Science & Services
    • Contexts of use
    • Pharmetheus Platforms
    • Solutions
    • Specific services
    • Publications
    • Case studies
  • Quick links
    • About us
    • Events
    • News
    • Careers
    • Contact us
    • Newsletter

About Pharmetheus

Pharmetheus is a consultancy firm helping clients reduce uncertainty in technical and regulatory processes, increasing confidence in the development of new medicines that can improve patients’ lives.

Gasell 2017
Gasell 2020
Gasell 2021
Gasell 2022
Gasell 2023
Gasell 2024

Copyright © Pharmetheus AB 2026

  • Whistleblower
  • Privacy Policy
  • Cookie Policy